Characteristics of patients with primary sclerosing cholangitis (PSC) who developed cholangiocarcinoma or bile duct dysplasia during the follow up investigation
| Age | First PSC diagnosis | K-ras mutation | Follow up investigation | Remarks | ||||
| 45 y | 1974 | 7/97 | 9/98 Carcinoma | Diagnosis of cholangiocarcinoma by CT scan and cytology. | ||||
| Normal CA19-9; T4N1M0. | ||||||||
| 36 y | 1996 | 1/96 | 1/99 Carcinoma | Diagnosis of cholangiocarcinoma by CT scan and cytology. | ||||
| Normal CA19-9; T4N1M0. | ||||||||
| 31 y | 1996 | 5/96 | 6/96 Carcinoma | Incidental diagnosis of cholangiocarcinoma during OLT. | ||||
| CA19-9: 762 kU/l; T1N0M1. | ||||||||
| 34 y | 1993 | 7/96 | 8/97 Carcinoma | Incidental diagnosis of cholangiocarcinoma during OLT. | ||||
| Normal CA19-9; T1N0M1. | ||||||||
| 34 y | 1989 | 4/96 | 7/97 Dysplasia | Diagnosis of bile duct dysplasia in explanted liver (OLT 7/97). | ||||
| 39 y | 1983 | 4/97 | 5/97 Dysplasia | Diagnosis of bile duct dysplasia in explanted liver (OLT 5/97). | ||||
CT, computed tomography; OLT, orthotopic liver transplantation.